Applied Therapeutics (APLT) announced the promotions of Evan Bailey to chief medical officer, effective June 15 and Dottie Caplan to executive VP, patient advocacy and government affairs. Bailey, who previously served as senior VP, clinical development at Applied, will be responsible for leading Applied’s clinical development and medical affairs activities as the company continues to advance govorestat in two late-stage development programs. Bailey succeeds Riccardo Perfetti who has served as the company’s CMO since 2018 and will remain available to the company to help ensure a transition.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APLT:
- Applied Therapeutics Elects New Director at Annual Meeting
- Hold Rating for Applied Therapeutics Amid Mixed Results from Govorestat Trial
- Applied announces INSPIRE Phase 2/3 trial primary endpoint not significant
- Strategic Advancements and Regulatory Progress Drive Buy Rating for Applied Therapeutics
- Applied Therapeutics Reports Q1 2025 Financial Results